annual CFO:
-$107.69M+$50.73M(+32.02%)Summary
- As of today (May 21, 2025), PTCT annual cash flow from operations is -$107.69 million, with the most recent change of +$50.73 million (+32.02%) on December 31, 2024.
- During the last 3 years, PTCT annual CFO has risen by +$143.64 million (+57.15%).
- PTCT annual CFO is now -970.14% below its all-time high of -$10.06 million, reached on December 31, 2017.
Performance
PTCT Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$870.10M+$900.11M(+2999.96%)Summary
- As of today (May 21, 2025), PTCT quarterly cash flow from operations is $870.10 million, with the most recent change of +$900.11 million (+2999.96%) on March 1, 2025.
- Over the past year, PTCT quarterly CFO has increased by +$799.34 million (+1129.64%).
- PTCT quarterly CFO is now at all-time high.
Performance
PTCT quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$691.65M+$799.34M(+742.28%)Summary
- As of today (May 21, 2025), PTCT TTM cash flow from operations is $691.65 million, with the most recent change of +$799.34 million (+742.28%) on March 1, 2025.
- Over the past year, PTCT TTM CFO has increased by +$749.82 million (+1289.10%).
- PTCT TTM CFO is now at all-time high.
Performance
PTCT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
PTCT Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.0% | +1129.6% | +1289.1% |
| 3 y3 years | +57.1% | +993.3% | +378.2% |
| 5 y5 years | -9.2% | +1166.9% | +602.0% |
PTCT Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +69.8% | at high | +624.3% | at high | +293.9% |
| 5 y | 5-year | -9.2% | +69.8% | at high | +624.3% | at high | +293.9% |
| alltime | all time | -970.1% | +69.8% | at high | +624.3% | at high | +293.9% |
PTCT Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $870.10M(-3000.0%) | $691.65M(-742.3%) |
| Dec 2024 | -$107.69M(-32.0%) | -$30.00M(-61.0%) | -$107.69M(-39.5%) |
| Sep 2024 | - | -$76.99M(+7.8%) | -$177.97M(+54.1%) |
| Jun 2024 | - | -$71.45M(-201.0%) | -$115.50M(+98.6%) |
| Mar 2024 | - | $70.76M(-170.6%) | -$58.17M(-63.3%) |
| Dec 2023 | -$158.42M(-55.6%) | -$100.29M(+590.7%) | -$158.42M(-29.3%) |
| Sep 2023 | - | -$14.52M(+2.8%) | -$224.09M(-9.5%) |
| Jun 2023 | - | -$14.12M(-52.1%) | -$247.62M(-14.2%) |
| Mar 2023 | - | -$29.49M(-82.2%) | -$288.74M(-19.0%) |
| Dec 2022 | -$356.65M(+41.9%) | -$165.96M(+336.2%) | -$356.65M(+37.4%) |
| Sep 2022 | - | -$38.05M(-31.1%) | -$259.53M(-4.8%) |
| Jun 2022 | - | -$55.24M(-43.3%) | -$272.68M(+9.7%) |
| Mar 2022 | - | -$97.40M(+41.5%) | -$248.58M(-1.1%) |
| Dec 2021 | -$251.33M(+29.5%) | -$68.84M(+34.5%) | -$251.33M(+1.8%) |
| Sep 2021 | - | -$51.19M(+64.4%) | -$246.86M(+46.1%) |
| Jun 2021 | - | -$31.14M(-68.9%) | -$169.01M(-20.5%) |
| Mar 2021 | - | -$100.16M(+55.6%) | -$212.67M(+9.6%) |
| Dec 2020 | -$194.07M(+96.7%) | -$64.37M(-341.4%) | -$194.07M(+38.7%) |
| Sep 2020 | - | $26.66M(-135.6%) | -$139.91M(-23.2%) |
| Jun 2020 | - | -$74.81M(-8.3%) | -$182.07M(+32.1%) |
| Mar 2020 | - | -$81.55M(+699.1%) | -$137.78M(+39.7%) |
| Dec 2019 | -$98.64M(+256.9%) | -$10.21M(-34.2%) | -$98.64M(-4.8%) |
| Sep 2019 | - | -$15.50M(-49.2%) | -$103.58M(+22.3%) |
| Jun 2019 | - | -$30.52M(-28.0%) | -$84.70M(+56.3%) |
| Mar 2019 | - | -$42.41M(+180.1%) | -$54.17M(+96.0%) |
| Dec 2018 | -$27.64M | -$15.14M(-548.4%) | -$27.64M(-414.5%) |
| Sep 2018 | - | $3.38M(>+9900.0%) | $8.79M(-184.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $3000.00(-100.0%) | -$10.36M(-449.7%) |
| Mar 2018 | - | -$15.88M(-174.6%) | $2.96M(-129.4%) |
| Dec 2017 | -$10.06M(-90.3%) | $21.29M(-235.0%) | -$10.06M(-77.5%) |
| Sep 2017 | - | -$15.77M(-218.4%) | -$44.67M(-15.7%) |
| Jun 2017 | - | $13.32M(-146.1%) | -$52.98M(-41.7%) |
| Mar 2017 | - | -$28.90M(+117.0%) | -$90.88M(-12.2%) |
| Dec 2016 | -$103.57M(-16.7%) | -$13.32M(-44.7%) | -$103.57M(-14.1%) |
| Sep 2016 | - | -$24.07M(-2.1%) | -$120.58M(-3.0%) |
| Jun 2016 | - | -$24.59M(-40.9%) | -$124.27M(-4.0%) |
| Mar 2016 | - | -$41.59M(+37.1%) | -$129.50M(+4.2%) |
| Dec 2015 | -$124.34M(+117.1%) | -$30.33M(+9.3%) | -$124.34M(+21.9%) |
| Sep 2015 | - | -$27.76M(-6.9%) | -$102.00M(+11.8%) |
| Jun 2015 | - | -$29.82M(-18.1%) | -$91.27M(+13.7%) |
| Mar 2015 | - | -$36.42M(+355.7%) | -$80.26M(+40.1%) |
| Dec 2014 | -$57.27M(+22.1%) | -$7.99M(-53.1%) | -$57.27M(-10.1%) |
| Sep 2014 | - | -$17.04M(-9.4%) | -$63.74M(+22.9%) |
| Jun 2014 | - | -$18.81M(+40.0%) | -$51.88M(-1.2%) |
| Mar 2014 | - | -$13.44M(-7.1%) | -$52.51M(+11.9%) |
| Dec 2013 | -$46.92M(-2.1%) | -$14.46M(+179.4%) | -$46.92M(+7.9%) |
| Sep 2013 | - | -$5.18M(-73.4%) | -$43.50M(-2.3%) |
| Jun 2013 | - | -$19.43M(+147.7%) | -$44.52M(+13.6%) |
| Mar 2013 | - | -$7.85M(-28.9%) | -$39.20M(-18.2%) |
| Dec 2012 | -$47.93M(+130.8%) | -$11.04M(+78.1%) | -$47.93M(+29.9%) |
| Sep 2012 | - | -$6.20M(-56.1%) | -$36.89M(+20.2%) |
| Jun 2012 | - | -$14.12M(-14.8%) | -$30.70M(+85.2%) |
| Mar 2012 | - | -$16.58M | -$16.58M |
| Dec 2011 | -$20.77M | - | - |
FAQ
- What is PTC Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for PTC Therapeutics?
- What is PTC Therapeutics annual CFO year-on-year change?
- What is PTC Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for PTC Therapeutics?
- What is PTC Therapeutics quarterly CFO year-on-year change?
- What is PTC Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for PTC Therapeutics?
- What is PTC Therapeutics TTM CFO year-on-year change?
What is PTC Therapeutics annual cash flow from operations?
The current annual CFO of PTCT is -$107.69M
What is the all time high annual CFO for PTC Therapeutics?
PTC Therapeutics all-time high annual cash flow from operations is -$10.06M
What is PTC Therapeutics annual CFO year-on-year change?
Over the past year, PTCT annual cash flow from operations has changed by +$50.73M (+32.02%)
What is PTC Therapeutics quarterly cash flow from operations?
The current quarterly CFO of PTCT is $870.10M
What is the all time high quarterly CFO for PTC Therapeutics?
PTC Therapeutics all-time high quarterly cash flow from operations is $870.10M
What is PTC Therapeutics quarterly CFO year-on-year change?
Over the past year, PTCT quarterly cash flow from operations has changed by +$799.34M (+1129.64%)
What is PTC Therapeutics TTM cash flow from operations?
The current TTM CFO of PTCT is $691.65M
What is the all time high TTM CFO for PTC Therapeutics?
PTC Therapeutics all-time high TTM cash flow from operations is $691.65M
What is PTC Therapeutics TTM CFO year-on-year change?
Over the past year, PTCT TTM cash flow from operations has changed by +$749.82M (+1289.10%)